Dr. Dan Selchen discusses new insights into early diagnosis of MS and assessing a patient’s long-term prognosis while at ECTRIMS 2015 in Barcelona, Spain.
This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.
Determining an MS Patient's Long-Term Prognosis
Facebook Comments